Lastly, a recent study performed by Liu and coworkers demonstrated that BA mitigates hepatic and muscular insulin resistance through activation of the PI3K/AKT signal pathway, both in vitro and in vivo. The gene discussed is AKT1; the disease is Insulin resistance.